HSFY8P

Across TCGA pan-cancer cohorts, HSFY8P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated HSFY8P data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher HSFY8P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HSFY8P expression acts as an unfavorable survival marker.

LGG and PRAD are the cancer types where HSFY8P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Tertile	All	0.185	0.738	.003	36	view →
PRAD	DFS	Tertile	All	0.790	0.936	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

HSFY8P–LGG (DFS)

Open the LGG breakdown →